About this trial
Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Double-Blind Controlled Trial
Eligibility criteria
Qualifiers
Adult patient aged 18 to 60 years inclusive
Patient diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD), combined or predominantly inattentive presentation, previously established by a healthcare professional
Patients must be registered in the active caseload of the Adult Neurodevelopmental Disorders Unit (STNDA)
Stable psychotropic medication regimen for at least four weeks prior to inclusion, in terms of both molecule and dosage, particularly for methylphenidate, or no current psychotropic treatment. Medication must remain unchanged throughout study participation, unless medically justified changes are required
Disqualifiers
Diagnosis of Autism Spectrum Disorder (ASD)
Diagnosis of personality disorder (Cluster A, B, C, or other), according to DSM-5-TR
Diagnosis of schizophrenia spectrum disorder or other psychotic disorders according to DSM-5-TR
Diagnosis of bipolar disorder with manic episode or history of manic episodes according to DSM-5-TR
Trial design
Treatments tested in this trial
- Transcranial direct current stimulation (tDCS)